Media Contact:
Sophia Friesen
Manager, Science Communications, 香蕉视频 of Utah Health
Email: sophia.friesen@hsc.utah.edu
鈥淢irror life鈥濃攁 synthetic organism, mirror-reversed on the molecular level from natural life鈥攕ounds like an impossibility. And so far, it is鈥攅ven the simplest mirror bacterium would be dramatically too complex for scientists to attempt making.
But while mirror life is still a hypothetical, it may not always be. Advances in technology could bring the generation of mirror life into the realm of possibility within decades. Mirror-image bacteria could be a boon to drug development鈥攂ut could also interact with the environment in unpredictable and potentially dangerous ways.
professor of biochemistry in the Spencer Fox Eccles School of Medicine at 香蕉视频 of Utah and an expert on mirror-image pharmaceuticals, shares the science of mirror life and why he thinks it should remain hypothetical.
What is mirror life?
To talk about mirror life, I need to first talk about regular life. All of the biomolecules that make up life, like DNA and proteins, have a handedness to them, just like your hands. They could, in theory, come in a left-handed or a right-handed version. Billions of years ago, life on Earth standardized on left-handed proteins. All life that evolved from that has continued to use left-handed proteins.
So when we're talking about mirror-image life, it's kind of like a 鈥渨hat if鈥 experiment: What if we constructed life with right-handed proteins instead of left-handed proteins? Something that would be very, very similar to natural life, but doesn鈥檛 exist in nature. We call this mirror-image life or mirror life. This type of life would only exist if it was made synthetically.
Why might scientists try to make mirror life?
We're one of the leading groups that is interested in this, and our interest is largely in mirror-image therapeutics.
If you give therapeutics to a person, especially protein or nucleic acid therapeutics, digestive enzymes in the body break them down rapidly, sometimes within minutes. This can make it very challenging to treat chronic illnesses in a way that's cost-effective and convenient.
But mirror molecules are not recognized by those digestive enzymes, so they have the potential to last for a much longer period of time and to open up a whole new class of therapeutics that would allow us to treat a variety of diseases that are currently challenging.
鈥–urrently, we make mirror therapeutics chemically, stitching them together atom by atom. If we had mirror bacteria, which could make these for us, that could be a route to much more efficient large-scale production of mirror therapeutics.
What are the risks of creating an entire mirror bacterium?
A mirror organism would interact with the rest of our world in unpredictable, uncertain ways.
There is a plausible threat that mirror life could replicate unchecked, because it would be unlikely to be controlled by any of the natural mechanisms that prevent bacteria from overgrowing.
These are things like predators of the bacteria that help to keep it under control, antibiotics and the immune system, which are not expected to work on a mirror organism, and digestive enzymes.
There is a real possibility that mirror bacteria would struggle to find enough food to eat in order to grow, but we are humble in the face of evolution.
If these bacteria are able to grow at all鈥攁nd there is evidence that they probably would be able to grow, at least to some extent, in our natural world鈥攎aybe, over time, they could evolve the ability to eat our food and convert it to mirror food. If that happened, that would release a brake on their growth, and then all these other controlling mechanisms, as far as we can tell, would not be effective against these mirror bacteria.
But there's a lot of uncertainty in this determination. At this point, we don't have enough information to make a definitive estimate of what the risk would be.
How far out are scientists from creating a mirror bacterium?
What鈥檚 really critical is that people know there isn鈥檛 an imminent risk. We've never built something even close to as complex as an entire bacterial cell. It鈥檚 incredibly difficult, and new technologies are still needed to do that in a sufficiently efficient way.
But we're in a very exciting period in synthetic biology right now where new technologies, chemical synthesis, and minimal cell development are moving fast, which is why we thought this was a good time to really have this discussion as those foundational technologies are starting to develop and emerge.
I think the best time estimate we have is that we're probably one to three decades away from something like this being possible, if we made the decision to make this a priority. It would take tremendous resources and the cooperation of a huge consortium of international scientists with specialties in different aspects of cell construction.鈥
This is definitely not going to happen overnight. But it's not so far into the future that we think that it's something we can just hope won't happen for a while.
What should we be doing to mitigate the risks of mirror life being made?
We hope that this commentary will kick off extensive discussions on this topic with a broad group of stakeholders. We plan to start having international conferences in the coming year to discuss the risks and work with international agencies to develop a regulatory framework that would allow us to prevent those risks.
This wouldn't affect anybody's current research. We think there's an opportunity, before anyone's livelihood depends on this, to define responsible lines of research, lines that should be carefully evaluated by regulatory authorities, and the lines we shouldn't cross.
It鈥檚 important to differentiate between mirror life and benign uses of mirror technology which are already underway. Mirror drugs are in development right now, including by our lab. Because these are chemically made, there is no risk of them posing any of the dangers that exclusively come with making a self-replicating mirror bacteria.
Once a mirror cell is made, it's going to be incredibly difficult to try to put that genie back in the bottle. That鈥檚 a big motivation for why we're thinking about prevention and regulation well ahead of any potential actual risk.
###
A commentary by Kay and other experts is published in Science as
Banner image has been modified and is credit NIAID.